Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, December 15, 2023
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
[ Fri, Dec 15th 2023
] - WOPRAI
Glen Santangelo Reiterated (VRCA) at Strong Buy and Held Target at $10 on, Dec 15th, 2023
Glen Santangelo of Jefferies, Reiterated "Verrica Pharmaceuticals Inc." (VRCA) at Strong Buy and Held Target at $10 on, Dec 15th, 2023.
Glen has made no other calls on VRCA in the last 4 months.
There are 2 other peers that have a rating on VRCA. Out of the 2 peers that are also analyzing VRCA, 0 agree with Glen's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Glen
- Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $8 on, Friday, November 10th, 2023
- Oren Livnat of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $12 on, Thursday, October 12th, 2023
